Occlude Defect ,
To provide global doctors and patients with safe and innovate medical devices to treat cardiovascular diseases
Being an innovative company, we consistently explore new idea and methods
On September 14, 2017, the China Brand Show Poland 2017 was launched in Warsaw, Poland.
2017 CPCS was held in Chongqing from September 1 to 3, 2017.
In August 2017, a team led by Prof. Hua Yimin, director of the Department of Pediatric Cardiology of the West China Second University Hospital of Sichuan University, successfully performed minimally invasive interventional occlusions for congenital heart diseases for more than ten pediatric patients from Ganzi Prefecture, Sichuan Province. All patients were treated using LifeTech's occluders.
On Aug. 20th, 2015, the HeartR ASD/PDA/VSD Occluder manufactured by Lifetech got approval in Taiwan, which means these products can be advanced into Taiwan.
On Jane 22th, 2015, SeQure™ snare system of Lifetech got local approval in Brazil, the product is allowed to be sold in Brazil.
On May.6th,2015, CeraFlex™ series of products (including CeraFlex™ ASD Occluder, CeraFlex™PDA Occluder and CeraFlex™ PFO Occluder)and SteerEaseTM of Lifetech got local approval in Saudi Arabia
Lifetech is a leading developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders.
Founded in 1999, we are now the second largest provider of congenital heart defect occluders in the world and the largest provider to BRIC countries.